Abstract
Background: Adenosine receptor family, especially A1 type is-overexpressed in breast-derived tumor cells and the P53 gene is mutant in some of these cells while the casps gene is of wild type as well. The aim of this study was to evaluate the effect of the A1 receptor function on cell programmed death or proliferation, as well as the relationship between this receptor stimulation/inhibition and caspase 3 (casp3) expression in T47D cell line that has a mutant and non-functional P53 gene. Materials and Methods: The expression of casps3 was measured by real-time polymerase chain reaction and then flow cytometery and MTT assay were used to assess the apoptotic and proliferation cell rate after the treatment of T47D cells with specific agonist N6-cyclopentyladenosine (CPA) and antagonist 1,3-dipropyl-8-cyclopentylxanthine (DPCPX) of this receptor 24, 48, and 72 hours after treatment. Result: Our results indicated that DPCPX significantly induces apoptosis in T47D cells and the rate of survival cell after the reduction of this treatment, especially 72 hours after treatment. Finally, the expression of casp3 was up-regulated by DPCPX treatment, especially in 72 hours while CPA treatment had opposite results (P>0.05). Conclusion: In general, DPCPX could up-regulate casp3 gene expression and subsequently increase the apoptosis rate in T47D cells with casp3 expression without the P53 gene interference. Therefore, adenosine A1 receptor antagonists may be introduced as anti-cancer agents.
Highlights
The tumors of the breast are prevalent malignancy and occur in one-eighth of the population of women in developed countries and the mortality rate of this cancer is closed to 30% [1, 2]
The results further indicated that DPCPX treatment arrested T47D cell proliferation and induced apoptosis up to 65% in 72 hours
In general, the findings showed that the antagonist of the adenosine A1 receptor induced significant apoptosis in P53-mutated T47D cells in the concentration range of 180 nM by up-regulating the casp3 gene
Summary
The tumors of the breast are prevalent malignancy and occur in one-eighth of the population of women in developed countries and the mortality rate of this cancer is closed to 30% [1, 2]. Cancerous cells have many different mechanisms to deviate from normal proliferation and growth control pathways. The breast cancer cell often over-expresses the adenosine A1 receptor [5]. Especially A1 type is-overexpressed in breast-derived tumor cells and the P53 gene is mutant in some of these cells while the casps gene is of wild type as well. Materials and Methods: The expression of casps was measured by real-time polymerase chain reaction and flow cytometery and MTT assay were used to assess the apoptotic and proliferation cell rate after the treatment of T47D cells with specific agonist N6-cyclopentyladenosine (CPA) and antagonist 1,3-dipropyl-8-cyclopentylxanthine (DPCPX) of this receptor 24, 48, and 72 hours after treatment. The expression of casp was up-regulated by DPCPX treatment, especially in 72 hours while CPA treatment had opposite results (P > 0.05).
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
